Isopropyl Alcohol in Pharmaceutical Manufacturing: ICH Q3C Class 3 and Residue Limits

2-Propanol (CAS 67-63-0; isopropanol; IPA) is a water-miscible secondary alcohol with molecular weight 60.10 g/mol, density approximately 0.785 g/cm³ at 20 °C, boiling point 82.3 °C, vapor pressure approximately 4.4 kPa at 20 °C, and closed-cup flash point 12 °C. In pharmaceutical manufacturing, the material functions as a granulation liquid, a film-coating solvent, an extraction solvent, and a sanitizing agent for stainless-steel product-contact surfaces. Because the solvent is residual after drying and is present in multi-solvent process streams, the ICH Q3C residual solvent guideline classifies 2-propanol in Table 3 as a Class 3 solvent.

Compendial grade 2-propanol is controlled by the USP Isopropyl Alcohol monograph and the Ph. Eur. Isopropyl alcohol monograph for identity, relative density, absorbance, water content, and non-volatile residue. Those compendial controls are separate from the residual solvent controls applied to the finished drug product. USP <467> and Ph. Eur. 2.4.24 provide the harmonized analytical framework for residual solvent testing.

Production-scale use of 2-propanol is documented across several unit operations. In high-shear granulation, the liquid is sprayed through a nozzle at a rate controlled by the power consumption of the main impeller. In film coating, IPA-based coating solutions are applied in perforated pan coaters with inlet air temperature controlled below the solvent flash point and with explosion-rated extraction. These applications generate residual solvent in the intermediate or coated dosage form; therefore, the drying profile and method of addition are recorded as part of the process validation.

Because the closed-cup flash point is 12 °C, process areas where 2-propanol is handled require explosion-proof electrical classification, solvent-resistant gaskets, and continuous LEL monitoring. These controls are separate from the residue limits but influence the drying equipment design, especially for fluid-bed dryers that recirculate drying gas.

What Class 3 Placement Means for 2-Propanol Under ICH Q3C

Class 3 solvents are defined in ICH Q3C(R8) as less toxic and of lower risk to human health than Class 1 or Class 2 solvents. 2-Propanol is included in Table 3 because available data show low acute and short-term toxicity and no positive genotoxicity findings at levels relevant to pharmaceutical residues. The guideline does not require a solvent-specific permitted daily exposure calculation for 2-propanol; instead, a class-based limit of 50 mg/day is applied. This class-based limit is equivalent to 0.5% w/w (5000 ppm) only when the daily product dose is 10 g or lower.

In practice, a formulation containing 2-propanol can be released without toxicological justification if the total daily intake of all Class 3 solvents is 50 mg/day or less. The limit is a control threshold, not a specification for the solvent as an impurity in the drug substance. For products with multiple Class 3 residues, the total daily intake of all Class 3 solvents is assessed against the same 50 mg/day threshold.

Residue Limit Calculation by Option 1 and Option 2

The ICH Q3C guideline provides two options for applying the 50 mg/day Class 3 limit. Under Option 1, the concentration limit is derived by dividing the daily intake limit by a fixed 10 g daily dose assumption. The resulting limit for 2-propanol is 5000 ppm (0.5% w/w). Option 1 is valid only when the maximum daily dose of the drug product does not exceed 10 g. Under Option 2, the analytical result in ppm is multiplied by the actual daily dose to obtain the daily intake in mg/day, which must be 50 mg/day or less.

The arithmetic form for Option 2 is: Daily intake (mg/day) = concentration (ppm) × dose (g/day) × 10⁻³. For a product dosed at 5 g/day, a measured residue of 4000 ppm gives 20 mg/day, which passes. For a product dosed at 20 g/day, the same 4000 ppm gives 80 mg/day, which exceeds the limit. This dose-dependent divergence is the main reason high-dose products require Option 2 evaluation even when the batch releases under the 5000 ppm Option 1 threshold.

When 2-propanol is used with acetone or ethanol in the same process, the individual residue results are not sufficient. The sum of Class 3 solvent intakes is calculated as the sum of each solvent concentration multiplied by the daily dose. A product with 2000 ppm IPA and 2500 ppm ethanol at 10 g/day has a combined intake of 45 mg/day, which is below 50 mg/day. At 12 g/day, the same concentrations give 54 mg/day and fail.

When High-Dose Formulations Exceed the 10 g Daily Intake Assumption

High-dose oral powders, suspensions, and some parenteral infusion formulations can exceed 10 g/day. In these cases, a residue level below 5000 ppm does not guarantee compliance. The actual daily dose becomes the multiplier. A 15 g/day product containing 3500 ppm 2-propanol results in 52.5 mg/day, which is above the Class 3 limit. For a 30 g/day dose, the concentration corresponding to the limit is 1667 ppm, not 5000 ppm. Manufacturers of such products must establish tighter in-process controls or select alternative solvents if drying cannot reliably reach the required residue.

Residual 2-propanol retention in high-dose granulations is often linked to the drying endpoint. The solvent forms a minimum-boiling azeotrope with water at approximately 87.7 wt% 2-propanol and 80.4 °C at 101.3 kPa; therefore, the final moisture content and the residual IPA level are coupled. A granulation discharged at low moisture may still retain IPA in amorphous regions or within intraparticle pores. Process validation batches must demonstrate that the drying cycle achieves the product-specific residual limit at the maximum dose, not merely at the average dose.

In fluid-bed drying of IPA-granulated products, the solvent is removed during the falling-rate drying period. The residual level is measured at the discharge moisture specification. Different granule size fractions can retain different IPA concentrations; a mean sample may therefore underestimate the maximum patient exposure if the dosage form is not homogeneous. Process validation protocols should include sampling from at least three locations of the dryer and should compare the highest residue result against the dose-weighted limit.

Quantification of residual 2-propanol in drug substances, excipients, and finished products is performed using static headspace gas chromatography with flame ionization detection. USP <467> and Ph. Eur. 2.4.24 describe harmonized procedures using a headspace sampler, a fused-silica capillary column of intermediate polarity, and an FID. Samples are dissolved or dispersed in a high-boiling diluent such as dimethyl sulfoxide or water; the choice of diluent affects the headspace partition coefficient and must be consistent between standards and samples. Method validation follows ICH Q2(R1) for specificity, linearity, accuracy, precision, range, and detection limit. A matrix-matched calibration curve is required because product excipients can alter the partition coefficient of 2-propanol relative to a neat solvent standard.

Headspace equilibration temperature and time are selected by evaluating the response of a spiked sample. Because 2-propanol has a relatively high vapor pressure, low equilibration temperatures may reduce matrix interference but can also reduce sensitivity. The method detection limit and quantitation limit are determined from the standard deviation of the response at low concentration, using the standard error of the regression line. Acceptance criteria for linearity are typically a correlation coefficient not less than 0.995, but the residual plot is more informative than the correlation coefficient for heteroscedasticity.

For release testing, the target concentration should be set below the limit to account for method variability. If the limit is 5000 ppm, a release specification such as 4000 ppm is common, but the numerical value must be justified by process capability and method precision. A headspace GC method with a relative standard deviation of 5% cannot safely discriminate a batch at 4900 ppm from one at 5100 ppm; the specification margin must be derived from method validation data. System suitability requires resolution of 2-propanol from ethanol and acetone, which elute in the same region on intermediate-polarity columns.

Managing 2-Propanol Carryover in Cleaning Validation

When 2-propanol is used as a cleaning agent for product-contact equipment, the residue is controlled under equipment cleaning requirements in 21 CFR 211.67 and the risk-based approach of ICH Q9. The acceptance limit for carryover can be derived from the Class 3 limit by calculating a maximum allowable carryover: MACO (mg) = [50 mg/day × next product batch size (mg)] / next product maximum daily dose (mg/day). The bulk carryover figure must then be converted to a surface residue limit using the equipment surface area and a swab recovery factor.

Swab recovery studies are performed on 316L stainless steel coupons with known amounts of 2-propanol. The measured recovery factor is applied to the analytical result because direct swabbing does not remove all solvent residues. If the recovery is 80%, a swab result of 80 µg corresponds to a surface burden of 100 µg. Without correction, the residue is underestimated and the batch may be released despite exceeding the calculated carryover limit. 2-Propanol evaporates rapidly from warm surfaces; therefore, sampling must be performed immediately after equipment cooling to prevent evaporative losses that invalidate the recovery model.

Rinse sampling is an alternative when swab sites are inaccessible. The rinse solvent is collected after a defined volume and contact time, and the result is converted to a total surface burden using the rinse volume and sampled surface area. For 2-propanol, rinse sampling has the advantage of integrating large areas, but evaporative loss during sample transfer must be controlled. Swab and rinse results are compared during method recovery studies to establish the relationship between the two techniques.

Manufacturers of 2-propanol-containing excipients face a different calculation. A binder or coating polymer with residual IPA of 3000 ppm may be acceptable only if the excipient use level and daily dose produce total IPA intake below 50 mg/day. For a tablet containing 200 mg of a polymer at 3000 ppm, the IPA contribution is 0.6 mg/tablet. At a dose of 4 tablets/day, the daily intake is 2.4 mg/day, which is acceptable. If the same excipient is used in a sachet at 5 g/day, the intake is 15 mg/day, still below the limit. These calculations are performed in the excipient vendor qualification plan and confirmed in the finished product release method.

Out-of-specification results for residual 2-propanol trigger an investigation under 21 CFR 211.192. The laboratory phase must exclude headspace vial leakage, septum contamination, and method error. If the OOS is confirmed, the process phase examines the drying curve, the addition rate of the granulating fluid, and the compressed air dew point. Multiple batches with the same root cause indicate a need for revalidation of the drying endpoint.